Procter & Gamble (NYSE:PG) Stock: Insider Balaji Purushothaman Sells 4,181 Shares

Key Points

• Insider sale: Balaji Purushothaman sold 4,181 Procter & Gamble shares for approximately $671,929, reducing his direct holdings by 27.01% to 11,296 shares.
• Strong quarterly results: PG reported $2.00 in earnings per share and $23.28 billion in revenue, exceeding analyst estimates, with revenue rising 4% year over year.
• Dividend and analyst support: The company declared a quarterly dividend of $1.0885, representing a 2.7% yield, while analysts maintained a “Moderate Buy” consensus and a $170.57 average price target.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) insider Balaji Purushothaman sold 4,181 shares of the business's stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $160.71, for a total transaction of $671,928.51. Following the sale, the insider directly owned 11,296 shares of the company's stock, valued at $1,815,380.16. This represents a 27.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Procter & Gamble Trading Down 0.8%

PG traded down $1.27 during trading hours on Monday, reaching $159.75. The company's stock had a trading volume of 2,540,729 shares, compared to its average volume of 9,731,445. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The business's 50-day moving average is $148.41 and its 200-day moving average is $147.12. The stock has a market cap of $370.27 billion, a PE ratio of 24.06, a P/E/G ratio of 4.00 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company's revenue was up 4.0% on a year-over-year basis. During the same period last year, the business earned $1.99 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is 65.51%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PG. Morgan Stanley lifted their price objective on Procter & Gamble from $166.00 to $185.00 and gave the company an "overweight" rating in a report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Procter & Gamble in a research report on Friday. The Goldman Sachs Group reiterated a "neutral" rating and issued a $161.00 target price on shares of Procter & Gamble in a research report on Thursday. Piper Sandler upped their price objective on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a "neutral" rating in a report on Monday. Finally, BNP Paribas Exane increased their target price on Procter & Gamble from $177.00 to $189.00 and gave the stock an "outperform" rating in a research report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $170.57.

Hedge Funds Weigh In On Procter & Gamble

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in Procter & Gamble in the second quarter valued at approximately $26,000. Montgomery Financial Services LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth about $28,000. Paladin Partners LLC purchased a new position in Procter & Gamble in the second quarter valued at approximately $29,000. Toews Corp ADV purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at $37,000. Finally, Evergreen Advisors LLC acquired a new position in Procter & Gamble during the first quarter worth approximately $37,000. Institutional investors and hedge funds own 65.77% of the company's stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analysts raise targets and ratings: TD Cowen, JPMorgan, BNP Paribas Exane and Citigroup reportedly see meaningful upside for PG, while Freedom Broker upgraded the stock to Buy. The cluster of favorable views may support investor confidence. JPMorgan raises Procter & Gamble price target
• Positive Sentiment: Recent earnings exceeded expectations: Procter & Gamble reported quarterly earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion topped expectations of $22.80 billion and increased 4% year over year. These results demonstrate resilient demand across the consumer-staples business. Procter & Gamble earnings report
• Positive Sentiment: Dividend appeal remains supportive: A retirement-focused comparison notes that both PG and Colgate-Palmolive recently raised dividends and exceeded earnings estimates, reinforcing PG’s defensive income-investment case. PG versus Colgate-Palmolive

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.